Outcomes | Acetaminophen users (n = 3892) | Non-users (n = 2860) | Univariable analysis | Multivariable analysis* | ||
---|---|---|---|---|---|---|
HR/OR (95% CI) | P-value | HR/OR (95% CI) | P-value | |||
Primary outcome | ||||||
28-day mortality†, n (%) | 970 (24.9) | 987 (34.5) | 0.65 (0.60–0.71) | < 0.001 | 0.69 (0.63–0.75) | < 0.001 |
Secondary outcomes | ||||||
ICU mortality†, n (%) | 574 (14.7) | 678 (23.7) | 0.50 (0.45–0.56) | < 0.001 | 0.56 (0.50–0.63) | < 0.001 |
In-hospital mortality†, n (%) | 811 (20.8) | 836 (29.2) | 0.59 (0.53–0.65) | < 0.001 | 0.62 (0.57–0.69) | < 0.001 |
90-day mortality†, n (%) | 1271 (32.7) | 1220 (42.7) | 0.68 (0.63–0.74) | < 0.001 | 0.73 (0.68–0.79) | < 0.001 |
1-year mortality†, n (%) | 1628 (41.8) | 1534 (53.6) | 0.69 (0.64–0.73) | < 0.001 | 0.75 (0.69–0.80) | < 0.001 |
Renal recovery‡, n (%) | 1721 (44.2) | 1106 (38.7) | 1.26 (1.14–1.39) | < 0.001 | 1.15 (1.04–1.28) | 0.007 |